Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Virchows Archiv : an International Journal of Pathology
|
June 3, 2017
Early detection: the impact of genomics
M C J van Lanschot, L J W Bosch, M de Wit, et al.
Virchows Archiv : an International Journal of Pathology
|
July 25, 2012
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers
E M V de Cuba, R Kwakman, M van Egmond, et al.
ESMO Open
|
June 12, 2025
The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma
P van der Laan, W J van Houdt, H van Boven, et al.
ESMO Open
|
December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
L J Schipper, K G Samsom, P Snaebjornsson, et al.
International Journal of Cancer
|
September 17, 2015
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
E M V de Cuba, P Snaebjornsson, D A M Heideman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 18, 2024
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort
J W T van der Wel, M Jebbink, D van den Broek, et al.
The American Journal of Gastroenterology
|
November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
L J W Bosch, V Melotte, S Mongera, et al.
BMC Cancer
|
August 22, 2020
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
S J Schraa, K L van Rooijen, D E W van der Kruijssen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
J W T van der Wel, S M Ernst, M Jebbink, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Virchows Archiv : an International Journal of Pathology
|
June 3, 2017
Early detection: the impact of genomics
M C J van Lanschot, L J W Bosch, M de Wit, et al.
Virchows Archiv : an International Journal of Pathology
|
July 25, 2012
Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers
E M V de Cuba, R Kwakman, M van Egmond, et al.
ESMO Open
|
June 12, 2025
The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma
P van der Laan, W J van Houdt, H van Boven, et al.
ESMO Open
|
December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
L J Schipper, K G Samsom, P Snaebjornsson, et al.
International Journal of Cancer
|
September 17, 2015
Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
E M V de Cuba, P Snaebjornsson, D A M Heideman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 18, 2024
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort
J W T van der Wel, M Jebbink, D van den Broek, et al.
The American Journal of Gastroenterology
|
November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population
L J W Bosch, V Melotte, S Mongera, et al.
BMC Cancer
|
August 22, 2020
Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
S J Schraa, K L van Rooijen, D E W van der Kruijssen, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study
J W T van der Wel, S M Ernst, M Jebbink, et al.
Page
of 1